PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth

Cancer stem cells (CSCs) play major roles in cancer initiation, progression, and metastasis. It is evident from growing reports that PI3K/Akt/mTOR and Sonic Hedgehog (Shh) signaling pathways are aberrantly reactivated in pancreatic CSCs. Here, we examined the efficacy of combining NVP-LDE-225 (PI3K/mTOR inhibitor) and NVP-BEZ-235 (Smoothened inhibitor) on pancreatic CSCs characteristics, microRNA regulatory network, and tumor growth. NVP-LDE-225 co-operated with NVP-BEZ-235 in inhibiting pancreatic CSC's characteristics and tumor growth in mice by acting at the level of Gli. Combination of NVP-LDE-225 and NVP-BEZ-235 inhibited self-renewal capacity of CSCs by suppressing the expression of pluripotency maintaining factors Nanog, Oct-4, Sox-2 and c-Myc, and transcription of Gli. NVP-LDE-225 co-operated with NVP-BEZ-235 to inhibit Lin28/Let7a/Kras axis in pancreatic CSCs. Furthermore, a superior interaction of these drugs was observed on spheroid formation by pancreatic CSCs isolated from Pankras/p53 mice. The combination of these drugs also showed superior effects on the expression of proteins involved in cell proliferation, survival and apoptosis. In addition, NVP-LDE-225 co-operated with NVP-BEZ-235 in inhibiting EMT through modulation of cadherin, vimentin and transcription factors Snail, Slug and Zeb1. In conclusion, these data suggest that the combined inhibition of PI3K/Akt/mTOR and Shh pathways may be beneficial for the treatment of pancreatic cancer.

[1]  Yi-Wei Chen,et al.  Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State. , 2015, Cancer research.

[2]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[3]  M. Fassnacht,et al.  Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer , 2015, Clinical endocrinology.

[4]  B. Ross,et al.  Dual inhibition of allosteric mitogen-activated protein kinase (MEK) and phosphatidylinositol 3-kinase (PI3K) oncogenic targets with a bifunctional inhibitor. , 2015, Bioorganic & medicinal chemistry.

[5]  Hongxia Ma,et al.  Genetic variants in let-7/Lin28 modulate the risk of oral cavity cancer in a Chinese Han Population , 2014, Scientific Reports.

[6]  S. Shankar,et al.  Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice. , 2014, Cancer letters.

[7]  Huafeng Zhang,et al.  Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1 , 2014, Nature Communications.

[8]  P. Bragado,et al.  Mechanisms of disseminated cancer cell dormancy: an awakening field , 2014, Nature Reviews Cancer.

[9]  K. W. Kim,et al.  NVP-BEZ-235 enhances radiosensitization via blockade of the PI3K/mTOR pathway in cisplatin-resistant non-small cell lung carcinoma , 2014, Genes & cancer.

[10]  Gemma K. Alderton.  Metastasis: Shedding is no easy task , 2014, Nature Reviews Cancer.

[11]  S. Shankar,et al.  Embelin Suppresses Growth of Human Pancreatic Cancer Xenografts, and Pancreatic Cancer Cells Isolated from KrasG12D Mice by Inhibiting Akt and Sonic Hedgehog Pathways , 2014, PloS one.

[12]  M. Ychou,et al.  Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies. , 2014, Cancer treatment reviews.

[13]  F. Briest,et al.  PI3K-AKT-mTOR-Signaling and beyond: the Complex Network in Gastroenteropancreatic Neuroendocrine Neoplasms , 2014, Theranostics.

[14]  M. Peter,et al.  MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells , 2014, Oncogene.

[15]  K. Haider,et al.  Sonic hedgehog signalling pathway: a complex network , 2014, Annals of neurosciences.

[16]  G. Daley,et al.  Lin28 Enhances Tissue Repair by Reprogramming Cellular Metabolism , 2013, Cell.

[17]  L. Poliseno,et al.  Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo , 2013, Pharmaceuticals.

[18]  Kang Xu,et al.  PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer. , 2013, Hepato-gastroenterology.

[19]  S. Shankar,et al.  Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice. , 2013, Cancer letters.

[20]  Anton J. Enright,et al.  LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. , 2013, Cancer research.

[21]  J. Ko,et al.  Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux. , 2013, Toxicology letters.

[22]  M. Lorenzo,et al.  Metabolic Rescue of Obese Adipose-Derived Stem Cells by Lin28/Let7 Pathway , 2013, Diabetes.

[23]  E. Giang,et al.  Corrigendum to “Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions” [Radiother Oncol 106 (2013) 138–146]☆ , 2013 .

[24]  S. Shankar,et al.  NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128 , 2013, Oncogenesis.

[25]  S. Roy,et al.  GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. , 2013, Cancer letters.

[26]  J. Waldron,et al.  Lin28b Promotes Head and Neck Cancer Progression via Modulation of the Insulin-Like Growth Factor Survival Pathway , 2012, Oncotarget.

[27]  S. Shankar,et al.  Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog–GLI pathway , 2012, Molecular and Cellular Biochemistry.

[28]  S. Shankar,et al.  Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics , 2012, International journal of cancer.

[29]  J. Bordeaux,et al.  Lin28 regulates HER2 and promotes malignancy through multiple mechanisms , 2012, Cell cycle.

[30]  C. Sarkar,et al.  Expression of sonic hedgehog during cell proliferation in the human cerebellum , 2012, International Journal of Developmental Neuroscience.

[31]  Dimitrios Iliopoulos,et al.  Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms , 2011, Cell.

[32]  S. Oh,et al.  Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. , 2011, Cancer research.

[33]  S. Shankar,et al.  Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms , 2011, PloS one.

[34]  Y. Seong,et al.  ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine. , 2011, Oncology reports.

[35]  P. Adams,et al.  Ras, PI3K/Akt and senescence , 2011, Small GTPases.

[36]  Ayellet V. Segrè,et al.  The Lin28/let-7 Axis Regulates Glucose Metabolism , 2011, Cell.

[37]  Ju-Seog Lee,et al.  LIN28B promotes colon cancer progression and metastasis. , 2011, Cancer research.

[38]  H. Johnsen,et al.  Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers , 2011, PloS one.

[39]  S. Shankar,et al.  Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition , 2011, PloS one.

[40]  J. Iovanna,et al.  Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects , 2010, TheScientificWorldJournal.

[41]  R. Gregory,et al.  MicroRNA-induced pluripotent stem cells , 2010, Cell stem cell.

[42]  Raoul Tibes,et al.  Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. , 2009, The New England journal of medicine.

[43]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[44]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[45]  Jeffrey A. Engelman,et al.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.

[46]  J. Taipale,et al.  Hedgehog: functions and mechanisms. , 2008, Genes & development.

[47]  F. Slack,et al.  let-7 microRNAs in development, stem cells and cancer. , 2008, Trends in molecular medicine.

[48]  Daniela Gabriel,et al.  Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity , 2008, Molecular Cancer Therapeutics.

[49]  Marie Evangelista,et al.  The Hedgehog Signaling Pathway in Cancer , 2006, Clinical Cancer Research.

[50]  N. Riobo,et al.  Hedgehog Signal Transduction: Signal Integration and Cross Talk in Development and Cancer , 2006, Cell cycle.

[51]  S. Nieuwenhuis,et al.  Neural mechanisms of attention and control: losing our inhibitions? , 2005, Nature Neuroscience.

[52]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[53]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[54]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[55]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[56]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[57]  P. De Camilli,et al.  Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production , 2003, Journal of biology.

[58]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[59]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[60]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[61]  Yutaka Shimada,et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.

[62]  Andrew P. McMahon,et al.  Sonic Hedgehog Is Required for Progenitor Cell Maintenance in Telencephalic Stem Cell Niches , 2003, Neuron.

[63]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[64]  J. Taipale,et al.  Patched acts catalytically to suppress the activity of Smoothened , 2002, Nature.

[65]  J. Avruch,et al.  Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.

[66]  G. Moreno-Bueno,et al.  Correlation of Snail expression with histological grade and lymph node status in breast carcinomas , 2002, Oncogene.

[67]  A. Whitty,et al.  Enhanced potency of human Sonic hedgehog by hydrophobic modification. , 2001, Biochemistry.

[68]  S. Cohen,et al.  Hedgehog Induces Opposite Changes in Turnover and Subcellular Localization of Patched and Smoothened , 2000, Cell.

[69]  John Calvin Reed,et al.  Endogenous Inhibitors of Caspases , 1999, Journal of Clinical Immunology.

[70]  C. James,et al.  Sporadic medulloblastomas contain PTCH mutations. , 1997, Cancer research.

[71]  Clifford J. Tabin,et al.  Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.

[72]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[73]  M. A. Stolow,et al.  Xenopus sonic hedgehog as a potential morphogen during embryogenesis and thyroid hormone-dependent metamorphosis , 1995, Nucleic Acids Res..

[74]  C. Nüsslein-Volhard,et al.  Mutations affecting segment number and polarity in Drosophila , 1980, Nature.

[75]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[76]  E. Giang,et al.  Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[77]  S. Shankar,et al.  Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. , 2011, Frontiers in bioscience.

[78]  Zhiwei Wang,et al.  Pancreatic cancer: understanding and overcoming chemoresistance , 2011, Nature Reviews Gastroenterology &Hepatology.

[79]  N. Agarwal,et al.  Metastatic potential of tumor-initiating cells in solid tumors. , 2011, Frontiers in bioscience.

[80]  I. Kim,et al.  Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. , 2010, International journal of radiation oncology, biology, physics.

[81]  David Hogg,et al.  Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.

[82]  J. Thiery,et al.  Modulations of the epithelial phenotype during embryogenesis and cancer progression. , 1994, Cancer treatment and research.